Literature DB >> 25738785

Point Prevalence, Clinical Characteristics, and Treatment Variation for Infants with Severe Bronchopulmonary Dysplasia.

Milenka Cuevas Guaman1, Jason Gien2, Christopher D Baker3, Huayan Zhang4, Eric D Austin5, Joseph M Collaco6.   

Abstract

OBJECTIVES: Despite improvements in survival of preterm infants, bronchopulmonary dysplasia (BPD) remains a persistent morbidity. The incidence, clinical course, and current management of severe BPD (sBPD) remain to be defined. To address these knowledge gaps, a multicenter collaborative was formed to improve outcomes in this population. STUDY
DESIGN: We performed a "snapshot" in eight neonatal intensive care units (NICUs) on December 17, 2013. A standardized clinical data form for each inpatient born at < 32 weeks was completed and collated centrally for analysis. sBPD was defined as receiving ≥ 30% supplemental oxygen and/or receiving positive pressure ventilation at 36 weeks postmenstrual age (PMA).
RESULTS: Of a total census of 710 inpatients, 351 infants were born at < 32 weeks and 128 of those (36.5%) met criteria for sBPD. The point prevalence of sBPD varied between centers (11-58%; p < 0.001). Among infants with sBPD there was a variation among centers in the use of mechanical ventilation at 28 days of life (p < 0.001) and at 36 weeks PMA (p = 0.001). We observed differences in the use of diuretics (p = 0.018), inhaled corticosteroids (p < 0.001), and inhaled β-agonists (p < 0.001).
CONCLUSION: The high point prevalence of sBPD and variable management among NICUs emphasizes the lack of evidence in guiding optimal care to improve long-term outcomes of this high-risk, understudied population. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25738785      PMCID: PMC4617756          DOI: 10.1055/s-0035-1547326

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  24 in total

1.  Policy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia.

Authors:  Kristi L Watterberg
Journal:  Pediatrics       Date:  2010-09-06       Impact factor: 7.124

Review 2.  Definitions and diagnostic criteria for bronchopulmonary dysplasia.

Authors:  Eduardo Bancalari; Nelson Claure
Journal:  Semin Perinatol       Date:  2006-08       Impact factor: 3.300

3.  Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.

Authors:  Richard A Ehrenkranz; Michele C Walsh; Betty R Vohr; Alan H Jobe; Linda L Wright; Avroy A Fanaroff; Lisa A Wrage; Kenneth Poole
Journal:  Pediatrics       Date:  2005-12       Impact factor: 7.124

4.  Respiratory severity score on day of life 30 is predictive of mortality and the length of mechanical ventilation in premature infants with protracted ventilation.

Authors:  Manish B Malkar; William P Gardner; George T Mandy; Michael R Stenger; Leif D Nelin; Edward G Shepherd; Stephen E Welty
Journal:  Pediatr Pulmonol       Date:  2014-03-10

5.  Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network.

Authors:  Barbara J Stoll; Nellie I Hansen; Edward F Bell; Seetha Shankaran; Abbot R Laptook; Michele C Walsh; Ellen C Hale; Nancy S Newman; Kurt Schibler; Waldemar A Carlo; Kathleen A Kennedy; Brenda B Poindexter; Neil N Finer; Richard A Ehrenkranz; Shahnaz Duara; Pablo J Sánchez; T Michael O'Shea; Ronald N Goldberg; Krisa P Van Meurs; Roger G Faix; Dale L Phelps; Ivan D Frantz; Kristi L Watterberg; Shampa Saha; Abhik Das; Rosemary D Higgins
Journal:  Pediatrics       Date:  2010-08-23       Impact factor: 7.124

6.  Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease.

Authors:  A A Hislop; S G Haworth
Journal:  Pediatr Pulmonol       Date:  1990

Review 7.  Bronchopulmonary dysplasia.

Authors:  John P Kinsella; Anne Greenough; Steven H Abman
Journal:  Lancet       Date:  2006-04-29       Impact factor: 79.321

8.  Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.

Authors:  Hyo Soon An; Eun Jung Bae; Gi Beom Kim; Bo Sang Kwon; Jae Suk Beak; Ee Kyung Kim; Han Suk Kim; Jung-Hwan Choi; Chung Il Noh; Yong Soo Yun
Journal:  Korean Circ J       Date:  2010-03-24       Impact factor: 3.243

9.  Tracheostomy placement in infants with bronchopulmonary dysplasia: safety and outcomes.

Authors:  George Mandy; Manish Malkar; Stephen E Welty; Rachel Brown; Edward Shepherd; William Gardner; Alicia Moise; Alfred Gest
Journal:  Pediatr Pulmonol       Date:  2012-05-08

10.  Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era.

Authors:  Ekta Khemani; Doff B McElhinney; Lawrence Rhein; Olyn Andrade; Ronald V Lacro; Kristin C Thomas; Mary P Mullen
Journal:  Pediatrics       Date:  2007-12       Impact factor: 7.124

View more
  28 in total

1.  Retrospective Analysis of an Interdisciplinary Ventilator Care Program Intervention on Survival of Infants with Ventilator-Dependent Bronchopulmonary Dysplasia.

Authors:  Jason Gien; John Kinsella; Jodi Thrasher; Alicia Grenolds; Steven H Abman; Christopher D Baker
Journal:  Am J Perinatol       Date:  2016-06-29       Impact factor: 1.862

2.  Predictors of length of stay for initial hospitalization in infants with bronchopulmonary dysplasia.

Authors:  Christopher B Morrow; Sharon A McGrath-Morrow; Joseph M Collaco
Journal:  J Perinatol       Date:  2018-06-08       Impact factor: 2.521

Review 3.  Bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis.

Authors:  G Al-Ghanem; P Shah; S Thomas; L Banfield; S El Helou; C Fusch; A Mukerji
Journal:  J Perinatol       Date:  2017-01-12       Impact factor: 2.521

4.  Tracheobronchomalacia Is Associated with Increased Morbidity in Bronchopulmonary Dysplasia.

Authors:  Erik B Hysinger; Nicholas L Friedman; Michael A Padula; Russell T Shinohara; Huayan Zhang; Howard B Panitch; Steven M Kawut
Journal:  Ann Am Thorac Soc       Date:  2017-06-16

5.  [An assessment of white matter development in preterm infants with bronchopulmonary dysplasia using diffusion tensor imaging].

Authors:  Yin-Juan Wang; Sha-Sha Liu; Yan-Chao Liu; Xiao-Nan Li; Rui-Li Zhang; Fa-Lin Xu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-10

6.  Acute Responses to Diuretic Therapy in Extremely Low Gestational Age Newborns: Results from the Prematurity and Respiratory Outcomes Program Cohort Study.

Authors:  Carol J Blaisdell; James Troendle; Anne Zajicek
Journal:  J Pediatr       Date:  2018-03-26       Impact factor: 4.406

7.  Interdisciplinary Care of Children with Severe Bronchopulmonary Dysplasia.

Authors:  Steven H Abman; Joseph M Collaco; Edward G Shepherd; Martin Keszler; Milenka Cuevas-Guaman; Stephen E Welty; William E Truog; Sharon A McGrath-Morrow; Paul E Moore; Lawrence M Rhein; Haresh Kirpalani; Huayan Zhang; Linda L Gratny; Susan K Lynch; Jennifer Curtiss; Barbara S Stonestreet; Robin L McKinney; Kevin C Dysart; Jason Gien; Christopher D Baker; Pamela K Donohue; Eric Austin; Candice Fike; Leif D Nelin
Journal:  J Pediatr       Date:  2016-11-28       Impact factor: 4.406

Review 8.  Bronchopulmonary dysplasia.

Authors:  Bernard Thébaud; Kara N Goss; Matthew Laughon; Jeffrey A Whitsett; Steven H Abman; Robin H Steinhorn; Judy L Aschner; Peter G Davis; Sharon A McGrath-Morrow; Roger F Soll; Alan H Jobe
Journal:  Nat Rev Dis Primers       Date:  2019-11-14       Impact factor: 52.329

9.  Improved growth and developmental activity post tracheostomy in preterm infants with severe BPD.

Authors:  Jun Luo; Suzanne Shepard; Kathleen Nilan; Audrey Wood; Heather M Monk; Erik A Jensen; Ann T Harrington; Kathryn Maschhoff; Haresh Kirpalani; Zhichun Feng; Huayan Zhang
Journal:  Pediatr Pulmonol       Date:  2018-07-03

10.  Therapeutic effects of fibroblast growth factor-10 on hyperoxia-induced bronchopulmonary dysplasia in neonatal mice.

Authors:  Tao Han; Ming Chi; Yan Wang; Yabo Mei; Qiuping Li; Mengnan Yu; Qianqian Ma; Yuhan Chen; Zhichun Feng
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.